← Leaderboards
David R Liu
Broad Institute, Inc.
$34,362,066
Attributed
$48,907,176
Total exposure
15
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.3M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$61,702,432 · 16
By mechanism
R01$19,679,500 · 7
U19$17,952,337 · 4
RM1$9,899,998 · 1
R35$6,380,621 · 1
UH3$3,277,908 · 1
UG3$2,402,907 · 1
Top collaborators
- Mitchell J Weiss6 shared
- Zheng-Yi Chen5 shared
- Brittany S. Adamson4 shared
- Martin Joseph Ankrah Aryee4 shared
- Jonathan S. Weissman4 shared
- Mandana Arbab3 shared
- Steven J Gray3 shared
- Ahmad Samir Khalil3 shared
Most similar at Broad Institute, Inc.
Same institution · by research overlap
- Mark J Daly$79,238,345
- Heidi L Rehm$158,514,803
- Satoshi Koyama$329,960
- Michael Boehnke$62,444,233
- Scott Topper$153,718,762
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsIn VivoProteinsEvolutionMediatingLaboratoriesGenesBiologicalGenome EditingTechnologyHuman DiseaseVariantGenomeSmall MoleculeIn VitroNovel StrategiesEnzymesGenetic DiseasesSpecificityResearch PersonnelLibrariesInterestClustered Regularly Interspaced Short Palindromic RepeatsGenomics
Grant awards (81)
Preclinical Genome Editing for Rare Neurological Diseases$4,319,346
U19 · FY2025 · NS
Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease$2,450,000
RM1 · FY2025 · HG
Base editing and prime editing for sickle cell disease$830,254
R01 · FY2025 · HL
ePACE: automation platforms for adaptable and scalable continuous evolution of biomolecules with therapeutic potential$815,764
R01 · FY2025 · EB
Project 3: Therapeutic Gene Editing for Huntington's Disease$666,838
U19 · FY2025 · NS · contact PI
Project 2: Therapeutic Gene Editing for Friedreich's Ataxia$644,059
U19 · FY2025 · NS · contact PI
Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics$635,211
R35 · FY2025 · GM · contact PI
Gene Editing Core$403,425
U19 · FY2025 · NS · contact PI
Preclinical Genome Editing for Rare Neurological Diseases$4,213,908
U19 · FY2024 · NS
Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease$2,449,998
RM1 · FY2024 · HG
ePACE: automation platforms for adaptable and scalable continuous evolution of biomolecules with therapeutic potential$804,366
R01 · FY2024 · EB
Base editing and prime editing for sickle cell disease$761,516
R01 · FY2024 · HL
Project 3: Therapeutic Gene Editing for Huntington's Disease$667,843
U19 · FY2024 · NS · contact PI
Project 2: Therapeutic Gene Editing for Friedreich's Ataxia$644,886
U19 · FY2024 · NS · contact PI
Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics$635,211
R35 · FY2024 · GM · contact PI
Continuous Evolution of Proteins with Novel Therapeutic Potential$609,416
R01 · FY2024 · EB · contact PI
Gene Editing Core$404,630
U19 · FY2024 · NS · contact PI
Preclinical Genome Editing for Rare Neurological Diseases$4,262,002
U19 · FY2023 · NS
Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease$2,500,000
RM1 · FY2023 · HG
ePACE: automation platforms for adaptable and scalable continuous evolution of biomolecules with therapeutic potential$871,502
R01 · FY2023 · EB
Base editing and prime editing for sickle cell disease$777,057
R01 · FY2023 · HL
Project 3: Therapeutic Gene Editing for Huntington's Disease$670,262
U19 · FY2023 · NS · contact PI
Project 2: Therapeutic Gene Editing for Friedreich's Ataxia$646,641
U19 · FY2023 · NS · contact PI
Continuous Evolution of Proteins with Novel Therapeutic Potential$621,853
R01 · FY2023 · EB · contact PI
Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics$591,065
R35 · FY2023 · GM · contact PI
Gene Editing Core$408,497
U19 · FY2023 · NS · contact PI
Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease$2,500,000
RM1 · FY2022 · HG
Efficient in Vivo RNP-based Gene Editing in the Sensory Organ Inner Ear Using Bioreducible Lipid Nanoparticles$1,639,716
UH3 · FY2022 · TR
Base editing and prime editing for sickle cell disease$715,670
R01 · FY2022 · HL
Continuous Evolution of Proteins with Novel Therapeutic Potential$621,853
R01 · FY2022 · EB · contact PI
Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics$591,065
R35 · FY2022 · GM · contact PI
Expanding the Scope of Base Editing$421,357
U01 · FY2022 · AI · contact PI
PedGeneRx - Admin Supplement to Base Editing and Prime Editing for Sickle Cell Disease R01$182,000
R01 · FY2022 · HL
Efficient in Vivo RNP-based Gene Editing in the Sensory Organ Inner Ear Using Bioreducible Lipid Nanoparticles$1,638,192
UH3 · FY2021 · TR
Base editing and prime editing for sickle cell disease$733,558
R01 · FY2021 · HL
Continuous Evolution of Proteins with Novel Therapeutic Potential$621,853
R01 · FY2021 · EB · contact PI
Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics$591,065
R35 · FY2021 · GM · contact PI
Expanding the Scope of Base Editing$421,536
U01 · FY2021 · AI · contact PI
Efficient in Vivo RNP-based Gene Editing in the Sensory Organ Inner Ear Using Bioreducible Lipid Nanoparticles$782,510
UG3 · FY2020 · TR
Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics$692,073
R35 · FY2020 · GM · contact PI
Expanding the Scope of Base Editing$421,760
U01 · FY2020 · AI · contact PI
Efficient in Vivo RNP-based Gene Editing in the Sensory Organ Inner Ear Using Bioreducible Lipid Nanoparticles$789,370
UG3 · FY2019 · TR
Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics$692,434
R35 · FY2019 · GM · contact PI
Continuous Evolution of Proteins with Novel Therapeutic Potential$451,488
R01 · FY2019 · EB · contact PI
Expanding the Scope of Base Editing$422,147
U01 · FY2019 · AI · contact PI
Efficient in Vivo RNP-based Gene Editing in the Sensory Organ Inner Ear Using Bioreducible Lipid Nanoparticles$831,027
UG3 · FY2018 · TR
Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics$692,783
R35 · FY2018 · GM · contact PI
Continuous Evolution of Proteins with Novel Therapeutic Potential$451,488
R01 · FY2018 · EB · contact PI
Expanding the Scope of Base Editing$422,361
U01 · FY2018 · AI · contact PI
Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics$618,244
R35 · FY2017 · GM · contact PI
Continuous Evolution of Proteins with Novel Therapeutic Potential$304,001
R01 · FY2017 · EB · contact PI
Continuous Evolution of Proteins with Novel Therapeutic Potential$147,487
R01 · FY2017 · EB · contact PI
Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics$69,587
R35 · FY2017 · GM · contact PI
Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics$571,883
R35 · FY2016 · GM · contact PI
Continuous Evolution of Proteins with Novel Therapeutic Potential$451,488
R01 · FY2016 · EB · contact PI
Synthesis and Discovery Enabled by Small Molecule-Nucleic Acid Conjugates$420,404
R01 · FY2015 · GM · contact PI
Synthesis and Discovery Enabled by Small Molecule-Nucleic Acid Conjugates$420,404
R01 · FY2014 · GM · contact PI
New Approaches for the Delivery of Proteins and Nucleic Acids Into Cells$326,462
R01 · FY2014 · GM · contact PI
Synthesis and Discovery Enabled by Small Molecule-Nucleic Acid Conjugates$405,690
R01 · FY2013 · GM · contact PI
New Approaches for the Delivery of Proteins and Nucleic Acids Into Cells$315,304
R01 · FY2013 · GM · contact PI
Synthesis and Discovery Enabled by Small Molecule-Nucleic Acid Conjugates$420,404
R01 · FY2012 · GM · contact PI
New Approaches for the Delivery of Proteins and Nucleic Acids Into Cells$327,010
R01 · FY2012 · GM · contact PI
Synthesis and Discovery Enabled by Small Molecule-Nucleic Acid Conjugates$350,621
R01 · FY2011 · GM · contact PI
New Approaches for the Delivery of Proteins and Nucleic Acids Into Cells$327,272
R01 · FY2011 · GM · contact PI
Synthesis and Discovery Enabled by Small Molecule-Nucleic Acid Conjugates$354,326
R01 · FY2010 · GM · contact PI
Expanding the Scope of Protein Evolution$283,576
R01 · FY2010 · GM · contact PI
Synthesis and Discovery Enabled by Small Molecule-Nucleic Acid Conjugates$571,200
R01 · FY2009 · GM · contact PI
Synthesis and Discovery Enabled by Small Molecule-Nucleic Acid Conjugates$358,061
R01 · FY2009 · GM · contact PI
Expanding the Scope of Protein Evolution$286,014
R01 · FY2009 · GM · contact PI
Synthesis and Discovery Enabled by Small Molecule-Nucleic Acid Conjugates$356,105
R01 · FY2008 · GM · contact PI
Expanding the Scope of Protein Evolution$284,735
R01 · FY2008 · GM · contact PI
Expanding the Scope of Protein Evolution$284,309
R01 · FY2007 · GM · contact PI
Synthesis and Discovery Through DNA-Templated Chemistry$360,329
R01 · FY2006 · GM · contact PI
Expanding the Scope of Protein Evolution$267,405
R01 · FY2006 · GM · contact PI
Synthesis and Discovery Through DNA-Templated Chemistry$369,000
R01 · FY2005 · GM
Expanding the Scope of Protein Evolution$273,840
R01 · FY2005 · GM
Synthesis and Discovery Through DNA-Templated Chemistry$369,000
R01 · FY2004 · GM
Expanding the Scope of Protein Evolution$273,840
R01 · FY2004 · GM
Synthesis and Discovery Through DNA-Templated Chemistry$367,125
R01 · FY2003 · GM
Expanding the Scope of Protein Evolution$273,840
R01 · FY2003 · GM
Expanding the Scope of Protein Evolution$260,610
R01 · FY2002 · GM